Veritas Genetics

Veritas Genetics is a personal genomics startup based in Danvers, Massachusetts.[1] It was co-founded in 2014 by George M. Church, Mirza Cifric, Preston Estep, and Jonathan Zhao.[2]

In 2018, the company launched its flagship product, myGenome, with the stated goal of providing consumers with information about their genetic risk for disease and allergic reactions based on whole-genome sequencing results. The company's decision to sell the product for only $199 per order during an initial period attracted media attention as this promotional price was far below traditional prices for consumer-grade genome sequencing at the time.[1][3][4][5][6]

CNBC included the company on its Disruptor 50 list in 2018[1] and 2019.[7]

In December 2019, the company announced that it was ceasing U.S. operations and laying off most of its employees due to its inability to raise further funding.[8]

In January 2020, the company reversed course and announced that it had obtained further funding, would resume U.S. operations, and would rehire many of its employees.[9]